These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 8863249)

  • 1. Is surgical ligation of a patent ductus arteriosus the preferred initial approach for the neonate with extremely low birth weight?
    Robie DK; Waltrip T; Garcia-Prats JA; Pokorny WJ; Jaksic T
    J Pediatr Surg; 1996 Aug; 31(8):1134-7. PubMed ID: 8863249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prophylactic surgical ligation of patent ductus arteriosus for prevention of mortality and morbidity in extremely low birth weight infants.
    Mosalli R; Alfaleh K
    Cochrane Database Syst Rev; 2008 Jan; 2008(1):CD006181. PubMed ID: 18254095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2008 Jan; (1):CD003951. PubMed ID: 18254035
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of outcome in 298 extremely low-birth-weight infants with patent ductus arteriosus.
    Alexander F; Chiu L; Kroh M; Hammel J; Moore J
    J Pediatr Surg; 2009 Jan; 44(1):112-7; disscusion 117. PubMed ID: 19159727
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya M; Ohlsson A; Shah S
    Cochrane Database Syst Rev; 2003; (3):CD003951. PubMed ID: 12917997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patent ductus arteriosus management and outcomes in Japan and Canada: comparison of proactive and selective approaches.
    Isayama T; Mirea L; Mori R; Kusuda S; Fujimura M; Lee SK; Shah PS;
    Am J Perinatol; 2015 Sep; 32(11):1087-94. PubMed ID: 25825965
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Variation and comparative effectiveness of patent ductus arteriosus pharmacotherapy in extremely low birth weight infants.
    ElHassan NO; Bird TM; King AJ; Ambadwar PB; Jaquiss RD; Kaiser JR; Robbins JM
    J Neonatal Perinatal Med; 2014 Jan; 7(3):229-35. PubMed ID: 25322995
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors affecting successful closure of hemodynamically significant patent ductus arteriosus with indomethacin in extremely low birth weight infants.
    Yang CZ; Lee J
    World J Pediatr; 2008 May; 4(2):91-6. PubMed ID: 18661761
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indomethacin prophylaxis for patent ductus arteriosus (PDA) in infants with a birth weight of less than 1250 grams.
    Supapannachart S; Khowsathit P; Patchakapati B
    J Med Assoc Thai; 1999 Nov; 82 Suppl 1():S87-92. PubMed ID: 10730525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mandatory Closure Versus Nonintervention for Patent Ductus Arteriosus in Very Preterm Infants.
    Sung SI; Chang YS; Chun JY; Yoon SA; Yoo HS; Ahn SY; Park WS
    J Pediatr; 2016 Oct; 177():66-71.e1. PubMed ID: 27453374
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Indomethacin prophylaxis or expectant treatment of patent ductus arteriosus in extremely low birth weight infants?
    Cordero L; Nankervis CA; Delooze D; Giannone PJ
    J Perinatol; 2007 Mar; 27(3):158-63. PubMed ID: 17251986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal necrotizing enterocolitis with intestinal perforation in extremely premature infants receiving early indomethacin treatment for patent ductus arteriosus.
    Fujii AM; Brown E; Mirochnick M; O'Brien S; Kaufman G
    J Perinatol; 2002; 22(7):535-40. PubMed ID: 12368968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Morbidities associated with patent ductus arteriosus in preterm infants. Nationwide cohort study.
    Härkin P; Marttila R; Pokka T; Saarela T; Hallman M
    J Matern Fetal Neonatal Med; 2018 Oct; 31(19):2576-2583. PubMed ID: 28651469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic Indomethacin Compared with Delayed Conservative Management of the Patent Ductus Arteriosus in Extremely Preterm Infants: Effects on Neonatal Outcomes.
    Liebowitz M; Clyman RI
    J Pediatr; 2017 Aug; 187():119-126.e1. PubMed ID: 28396025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced Hospital Mortality With Surgical Ligation of Patent Ductus Arteriosus in Premature, Extremely Low Birth Weight Infants: A Propensity Score-matched Outcome Study.
    Tashiro J; Perez EA; Sola JE
    Ann Surg; 2016 Mar; 263(3):608-14. PubMed ID: 25822689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ibuprofen for the treatment of a patent ductus arteriosus in preterm and/or low birth weight infants.
    Ohlsson A; Walia R; Shah S
    Cochrane Database Syst Rev; 2003; (2):CD003481. PubMed ID: 12804469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of patent ductus arteriosus and neonatal mortality/morbidities: adjustment for treatment selection bias.
    Mirea L; Sankaran K; Seshia M; Ohlsson A; Allen AC; Aziz K; Lee SK; Shah PS;
    J Pediatr; 2012 Oct; 161(4):689-94.e1. PubMed ID: 22703954
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical versus medical treatment with cyclooxygenase inhibitors for symptomatic patent ductus arteriosus in preterm infants.
    Malviya MN; Ohlsson A; Shah SS
    Cochrane Database Syst Rev; 2013 Mar; 2013(3):CD003951. PubMed ID: 23543527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of a repeat course of cyclooxygenase inhibitor to close a PDA is a risk factor for developing chronic lung disease in ELBW infants.
    Adrouche-Amrani L; Green RS; Gluck KM; Lin J
    BMC Pediatr; 2012 Jan; 12():10. PubMed ID: 22284694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Indomethacin prophylaxis, patent ductus arteriosus, and the risk of bronchopulmonary dysplasia: further analyses from the Trial of Indomethacin Prophylaxis in Preterms (TIPP).
    Schmidt B; Roberts RS; Fanaroff A; Davis P; Kirpalani HM; Nwaesei C; Vincer M;
    J Pediatr; 2006 Jun; 148(6):730-734. PubMed ID: 16769377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.